XML 24 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Financial Instruments Measured at Fair Value on a Recurring Basis
The following tables set forth the Company’s financial instruments that were measured at fair value on a recurring basis as of the dates indicated by level within the fair value hierarchy (in thousands):
September 30, 2020
Level 1Level 2Level 3Total
Unrestricted Balances(1)
Money market funds$— $— $— $— 
Certificates of deposit— 627,666 — 627,666 
Commercial paper— 417,902 — 417,902 
Corporate bonds— 363,701 — 363,701 
Total unrestricted cash equivalents and investments— 1,409,269 — 1,409,269 
Restricted Balances(2)
Money market funds35,323 — — 35,323 
Certificates of deposit— 536,269 — 536,269 
Commercial paper— 460,475 — 460,475 
Corporate bonds— 201,817 — 201,817 
U.S. treasury securities2,499 — — 2,499 
Total restricted cash equivalents and investments37,822 1,198,561 — 1,236,383 
Total unrestricted and restricted cash equivalents and investments$37,822 $2,607,830 $— $2,645,652 
_______________
(1)$219.3 million of cash, $203.8 million of money market deposit accounts and $621.0 million of term deposits are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $2.5 billion of cash and cash equivalents and short-term investments on the condensed consolidated balance sheets.
(2)$63.1 million of restricted cash, $8.6 million of a money market deposit account and $7.8 million of a restricted term deposit are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $1.3 billion of restricted cash and cash equivalents and restricted short-term investments on the condensed consolidated balance sheets.
December 31, 2019
Level 1Level 2Level 3Total
Unrestricted Balances(1)
Certificates of deposit$— $1,276,594 $— $1,276,594 
Commercial paper— 876,495 — 876,495 
Corporate bonds— 247,578 — 247,578 
Total unrestricted cash equivalents and short-term investments— 2,400,667 — 2,400,667 
Restricted Balances(2)
Money market funds19,250 — — 19,250 
Certificates of deposit— 608,828 — 608,828 
Commercial paper— 791,155 — 791,155 
Corporate bonds— 75,908 — 75,908 
Total restricted cash equivalents and investments19,250 1,475,891 — 1,495,141 
Total unrestricted and restricted cash equivalents and investments$19,250 $3,876,558 $— $3,895,808 
_______________
(1)$96.9 million of cash, $217.5 million of money market deposit accounts and $135.0 million of term deposits are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $2.9 billion of cash and cash equivalents and short-term investments on the condensed consolidated balance sheets.
(2)$56.4 million of restricted cash, $7.9 million of a money market deposit account and $7.8 million of a restricted term deposit are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $1.6 billion of restricted cash and cash equivalents and restricted short-term investments on the condensed consolidated balance sheets.
The fair value of the Company’s Level 1 financial instruments is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 fixed income securities is obtained from an independent pricing service,
which may use quoted market prices for identical or comparable instruments or model driven valuations using observable market data or inputs corroborated by observable market data. Level 3 instrument valuations are valued based on unobservable inputs and other estimation techniques due to the absence of quoted market prices, inherent lack of liquidity and the long-term nature of such financial instruments.
During the nine months ended September 30, 2020, the Company did not make any transfers between the levels of the fair value hierarchy.
Financial Instruments Measured at Fair Value on a Non-Recurring Basis
In March 2020, the Company purchased a non-marketable equity security for total cash consideration of $10.0 million that is classified in other investments on the condensed consolidated balance sheets. The non-marketable equity security will be remeasured to fair value upon the occurrence of observable transactions for an identical or similar investments of the same issuer or impairment. As of September 30, 2020, there were no remeasurement adjustments.